Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging

被引:55
作者
Jia, Zhongzheng [1 ]
Geng, Daoying [1 ]
Xie, Tianwen [2 ]
Zhang, Jiaoyan [3 ]
Liu, Ying [4 ]
机构
[1] Fudan Univ, Dept Radiol, Huashan Hosp, Shanghai 200040, Peoples R China
[2] Siemens Ltd, Applicat Specialist Team, Shanghai, Peoples R China
[3] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Dynamic contrast-enhanced; Extravascular extracellular space; Glioma; Grading; Neovascular permeability; Volume transfer constant; CEREBRAL BLOOD-VOLUME; MICROVASCULAR PERMEABILITY; HIGH-GRADE; K-TRANS; PERFUSION; TUMORS; DIFFERENTIATION; CANCER;
D O I
10.1016/j.jocn.2011.08.030
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study was designed to quantitatively analyse neovascular permeability in glioma by dynamic contrast-enhanced MRI (DCE-MRI). Forty-four patients with glioma were included in this study. The highest value of volume transfer constant (K-trans) and volume of extravascular extracellular space per unit volume of tissue (lie) were obtained and the differences in K-trans and V-e between low-grade glioma (LGG) and high-grade glioma (HGG) were analyzed. The correlations between K-trans. Ve and glioma grade were performed. Receiver operating characteristic (ROC) curve analyses were conducted. The values of K-trans and V-e of LGG were significantly lower than those of HGG. The correlation analysis demonstrated statistically significant relationships between K-trans and glioma grade, between V-e and glioma grade, and between K-trans and V-e. The ROC curve analyses of K-trans (0.035/min) and V-e (0.130) for differentiating LGG from HGG were statistically significant. Thus, DCE-MRI can be used to estimate neovascular permeability and for pre-operative grading of glioma. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:820 / 823
页数:4
相关论文
共 25 条
[1]  
Bulnes S, 2009, HISTOL HISTOPATHOL, V24, P693, DOI 10.14670/HH-24.693
[2]  
Cha S, 2006, AM J NEURORADIOL, V27, P409
[3]   Glioblastomas: Gliomagenesis, genetics, angiogenesis, and microenvironment [J].
Figarella-Branger, D. ;
Colin, C. ;
Tchoghandjian, A. ;
Baeza, N. ;
Bouvier, C. .
NEUROCHIRURGIE, 2010, 56 (06) :441-448
[4]   High-grade and low-grade gliomas: differentiation by using perfusion MR imaging [J].
Hakyemez, B ;
Erdogan, C ;
Ercan, I ;
Ergin, N ;
Uysal, S ;
Atahan, S .
CLINICAL RADIOLOGY, 2005, 60 (04) :493-502
[5]   Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma [J].
Jackson, A ;
Jayson, GC ;
Li, KL ;
Zhu, XP ;
Checkley, DR ;
Tessier, JJL ;
Waterton, JC .
BRITISH JOURNAL OF RADIOLOGY, 2003, 76 (903) :153-162
[6]   Measuring blood volume and vascular transfer constant from dynamic, T*2-weighted contrast-enhanced MRI [J].
Johnson, G ;
Wetzel, SG ;
Cha, S ;
Babb, J ;
Tofts, PS .
MAGNETIC RESONANCE IN MEDICINE, 2004, 51 (05) :961-968
[7]   Magnetic Resonance Perfusion and Permeability Imaging in Brain Tumors [J].
Lacerda, Saulo ;
Law, Meng .
NEUROIMAGING CLINICS OF NORTH AMERICA, 2009, 19 (04) :527-+
[8]   Prostate Cancer Detection With Multi-parametric MRI: Logistic Regression Analysis of Quantitative T2, Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI [J].
Langer, Deanna L. ;
van der Kwast, Theodorus H. ;
Evans, Andrew J. ;
Trachtenberg, John ;
Wilson, Brian C. ;
Haider, Masoom A. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (02) :327-334
[9]  
Law M, 2003, AM J NEURORADIOL, V24, P1989
[10]  
Lev MH, 1999, NEUROIMAG CLIN N AM, V9, P309